Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9662614rdf:typepubmed:Citationlld:pubmed
pubmed-article:9662614lifeskim:mentionsumls-concept:C0085490lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C1510458lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C0449444lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C1518896lld:lifeskim
pubmed-article:9662614lifeskim:mentionsumls-concept:C1112870lld:lifeskim
pubmed-article:9662614pubmed:issue2lld:pubmed
pubmed-article:9662614pubmed:dateCreated1998-8-13lld:pubmed
pubmed-article:9662614pubmed:abstractTextPositive control 1 (PC1) (n = 9) goats were injected transthoracically into the left lung with live Pasteurella haemolytica biovar A, serovar 1 (PhA1) in polyacrylate (PA) beads on days 0 and 21. Positive control 2 (PC2) (n = 6) goats were nebulized with live PhA1 and PA beads on days 0 and 21. Negative control (NC) goats (n = 6) were each injected transthoracically into the left lung with PA beads alone on days 0 and 21. Four groups (n = 6) were administered PA beads mixed with ultraviolet (UV) killed PhA1 on days 0 and 21. The treatment doses of bacteria for these groups were principal group 1 (PR1) injected into the left lung (7.7 x 10(10) cfu); PR2, 7.7 x 10(10) UV-killed PhA1 injected subcutaneously (SC); PR3, 7.7 x 10(10) UV-killed PhA1 injected SC only on day 21; PR4, nebulized with PA beads mixed with 5.6 x 10(10) cfu of UV-killed PhA1; and PR5, nebulized with PA beads mixed with 5 x 10(8) cfu of UV-killed PhA1. All goats were challenged transthoracically in the right lung with 1 x 10(8) cfu of live PhA1 on day 42 and necropsied on day 46. The sizes of consolidated lung lesions at the challenge site were used as a measure of immunity. The data show that the introduction of live PhA1 into the lungs of goats, either by injection or aerosolization, offers excellent protection against a subsequent homologous challenge. The data also demonstrate that two transthoracic injections (21 days apart) of UV-killed PhA1 (PR1), and subcutaneous injection of UV-killed PhA1(PR2) also offer excellent protection against a subsequent homologous live PhA1 challenge. One SC injection of UV-killed PhA1 (PR3) appears to offer only partial protection against a subsequent homologous live PhA1 challenge. Inhalation of UV-killed PhA1 mixed with PA beads (PR4 and PR5) induced no protection in goats against a subsequent live PhA1 transthoracic challenge.lld:pubmed
pubmed-article:9662614pubmed:languageenglld:pubmed
pubmed-article:9662614pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9662614pubmed:citationSubsetIMlld:pubmed
pubmed-article:9662614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9662614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9662614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9662614pubmed:statusMEDLINElld:pubmed
pubmed-article:9662614pubmed:monthAuglld:pubmed
pubmed-article:9662614pubmed:issn0343-8651lld:pubmed
pubmed-article:9662614pubmed:authorpubmed-author:StrausD CDClld:pubmed
pubmed-article:9662614pubmed:authorpubmed-author:PurdyC WCWlld:pubmed
pubmed-article:9662614pubmed:authorpubmed-author:CooleyJ DJDlld:pubmed
pubmed-article:9662614pubmed:issnTypePrintlld:pubmed
pubmed-article:9662614pubmed:volume37lld:pubmed
pubmed-article:9662614pubmed:ownerNLMlld:pubmed
pubmed-article:9662614pubmed:authorsCompleteYlld:pubmed
pubmed-article:9662614pubmed:pagination132-6lld:pubmed
pubmed-article:9662614pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:meshHeadingpubmed-meshheading:9662614-...lld:pubmed
pubmed-article:9662614pubmed:year1998lld:pubmed
pubmed-article:9662614pubmed:articleTitlePasteurella haemolytica ultraviolet-irradiated vaccine by parenteral and aerosol routes compared in the goat model.lld:pubmed
pubmed-article:9662614pubmed:affiliationConservation and Production Research Laboratory, USDA Agriculture Research Service, Bushland, TX 79012, USA.lld:pubmed
pubmed-article:9662614pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9662614pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9662614pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed